Identification of Efflux Pump Mutations in Pseudomonas aeruginosa from Clinical Samples

Efflux pumps are a specialized tool of antibiotic resistance used by Pseudomonas aeruginosa to expel antibiotics. The current study was therefore conducted to examine the expression of MexAB-OprM and MexCD-OprJ efflux pump genes. In this study, 200 samples were collected from Khyber Teaching Hospital (KTH) and Hayatabad Medical Complex (HMC) in Peshawar, Pakistan. All the isolates were biochemically identified by an Analytical Profile Index kit and at the molecular level by Polymerase Chain Reaction (PCR) utilizing specific primers for the OprL gene. A total of 26 antibiotics were tested in the current study using the guidelines of the Clinical and Laboratory Standard Institute (CLSI) and high-level resistance was shown to amoxicillin-clavulanic acid (89%) and low-level to chloramphenicol (1%) by the isolates. The antibiotic-resistant efflux pump genes MexA, MexB, OprM, MexR, MexC, MexD, OprJ, and NfxB were detected in 178 amoxicillin-clavulanic acid-resistant isolates. Mutations were detected in MexA, MexB, and OprM genes but no mutation was found in the MexR gene as analyzed by I-Mutant software. Statistical analysis determined the association of antibiotics susceptibility patterns by ANOVA: Single Factor p = 0.05. The in silico mutation impact on the protein structure stability was determined via the Dynamut server, which revealed the mutations might increase the structural stability of the mutants. The docking analysis reported that MexA wild protein showed a binding energy value of −6.1 kcal/mol with meropenem and the mexA mutant (E178K) value is −6.5 kcal/mol. The mexB wild and mutant binding energy value was −5.7 kcal/mol and −8.0 kcal/mol, respectively. Efflux pumps provide resistance against a wide range of antibiotics. Determining the molecular mechanisms of resistance in P. aeruginosa regularly will contribute to the efforts against the spread of antibiotic resistance globally.

[1]  A. Asgari,et al.  Expression of RND efflux pumps mediated antibiotic resistance in Pseudomonas aeruginosa clinical strains. , 2021, Microbial pathogenesis.

[2]  S. Farajnia,et al.  Molecular epidemiology and carbapenem resistance of Pseudomonas aeruginosa isolated from patients with burns. , 2021, Journal of wound care.

[3]  T. Z. Salehi,et al.  Evaluation of MexAB-OprM efflux pump and determination of antimicrobial susceptibility in Pseudomonas aeruginosa human and veterinary isolates , 2021, BULGARIAN JOURNAL OF VETERINARY MEDICINE.

[4]  A. Meliani The multifactorial resistance of Pseudomonas aeruginosa , 2020, EXCLI journal.

[5]  M. Abdel-Daim,et al.  Efflux MexAB-Mediated Resistance in P. aeruginosa Isolated from Patients with Healthcare Associated Infections , 2020, Pathogens.

[6]  N. Narayanan,et al.  Mutational and Phylogenetic Analysis of nfxB Gene in Multidrug-Resistant Clinical Isolates of Pseudomonas aeruginosa Hyperexpressing MexCD-OprJ Efflux Pump , 2019, Advances in Microbiology.

[7]  K. Ghazvini,et al.  Characterization of efflux pump-mediated resistance against fluoroquinolones among clinical isolates of Pseudomonas aeruginosa in the northeast of Iran and its association with mortality of infected patients , 2019 .

[8]  B. Glick,et al.  Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. , 2019, Biotechnology advances.

[9]  M. Katouli,et al.  Pseudomonas aeruginosa: A review of their Pathogenesis and Prevalence in Clinical Settings and the Environment , 2016 .

[10]  P. Ruggerone,et al.  AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity , 2015, Proceedings of the National Academy of Sciences.

[11]  N. Jabeen,et al.  Multi-drug resistant pseudomonas aeruginosa: a threat of nosocomial infections in tertiary care hospitals. , 2015, JPMA. The Journal of the Pakistan Medical Association.

[12]  R. Hancock,et al.  Pseudomonas aeruginosa: all roads lead to resistance. , 2011, Trends in microbiology.

[13]  S. Lory,et al.  Emergence of Pseudomonas aeruginosa Strains Producing High Levels of Persister Cells in Patients with Cystic Fibrosis , 2010, Journal of bacteriology.

[14]  V. Tam,et al.  Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes , 2010, Expert review of pharmacoeconomics & outcomes research.

[15]  E. Velázquez,et al.  Historical evolution and current status of the taxonomy of genus Pseudomonas. , 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[16]  A. E. El Solh,et al.  Update on the treatment of Pseudomonas aeruginosa pneumonia. , 2009, The Journal of antimicrobial chemotherapy.

[17]  Jean-Marie Meyer,et al.  Pyoverdines: pigments, siderophores and potential taxonomic markers of fluorescent Pseudomonas species , 2000, Archives of Microbiology.

[18]  N. Gotoh,et al.  Characterization of MexE–MexF–OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa , 1997, Molecular microbiology.